483 related articles for article (PubMed ID: 19254517)
1. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
Gentile S; Bellantuono C
J Clin Psychiatry; 2009 Mar; 70(3):414-22. PubMed ID: 19254517
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
3. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.
Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G
Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910
[TBL] [Abstract][Full Text] [Related]
4. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
[TBL] [Abstract][Full Text] [Related]
5. Publishing statistically significant results with questionable clinical importance: focus on antidepressant use in pregnancy.
Einarson A
J Clin Psychiatry; 2012 Nov; 73(11):1443-6. PubMed ID: 23218161
[No Abstract] [Full Text] [Related]
6. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
7. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
Diav-Citrin O; Shechtman S; Weinbaum D; Wajnberg R; Avgil M; Di Gianantonio E; Clementi M; Weber-Schoendorfer C; Schaefer C; Ornoy A
Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study.
Nordeng H; van Gelder MM; Spigset O; Koren G; Einarson A; Eberhard-Gran M
J Clin Psychopharmacol; 2012 Apr; 32(2):186-94. PubMed ID: 22367660
[TBL] [Abstract][Full Text] [Related]
9. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
[TBL] [Abstract][Full Text] [Related]
10. Antidepressant use in pregnancy: a critical review focused on risks and controversies.
Byatt N; Deligiannidis KM; Freeman MP
Acta Psychiatr Scand; 2013 Feb; 127(2):94-114. PubMed ID: 23240634
[TBL] [Abstract][Full Text] [Related]
11. Clinical management of perinatal depression: focus on paroxetine.
Newport DJ; Stowe ZN
Psychopharmacol Bull; 2003; 37 Suppl 1():148-66. PubMed ID: 14566197
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.
Gentile S
Acta Psychiatr Scand; 2011 Apr; 123(4):266-75. PubMed ID: 21261600
[TBL] [Abstract][Full Text] [Related]
13. Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Tuccori M; Montagnani S; Testi A; Ruggiero E; Mantarro S; Scollo C; Pergola A; Fornai M; Antonioli L; Colucci R; Corona T; Blandizzi C
Postgrad Med; 2010 Jul; 122(4):49-65. PubMed ID: 20675971
[TBL] [Abstract][Full Text] [Related]
14. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression.
Nulman I; Koren G; Rovet J; Barrera M; Pulver A; Streiner D; Feldman B
Am J Psychiatry; 2012 Nov; 169(11):1165-74. PubMed ID: 23128923
[TBL] [Abstract][Full Text] [Related]
15. The risk of major cardiac malformations associated with paroxetine use during the first trimester of pregnancy: a systematic review and meta-analysis.
Bérard A; Iessa N; Chaabane S; Muanda FT; Boukhris T; Zhao JP
Br J Clin Pharmacol; 2016 Apr; 81(4):589-604. PubMed ID: 26613360
[TBL] [Abstract][Full Text] [Related]
16. [SSRIs and pregnancy: a review of the literature].
Soufia M; Aoun J; Gorsane MA; Krebs MO
Encephale; 2010 Dec; 36(6):513-6. PubMed ID: 21130237
[TBL] [Abstract][Full Text] [Related]
17. Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome?
Haddad PM; Pal BR; Clarke P; Wieck A; Sridhiran S
J Psychopharmacol; 2005 Sep; 19(5):554-7. PubMed ID: 16166193
[TBL] [Abstract][Full Text] [Related]
18. Prenatal exposure to selective serotonin reuptake inhibitors and infant outcome.
Malm H
Ther Drug Monit; 2012 Dec; 34(6):607-14. PubMed ID: 23042258
[TBL] [Abstract][Full Text] [Related]
19. An imperfect literature and evidence-based medicine.
Freeman MP
J Clin Psychiatry; 2009 Mar; 70(3):412-3. PubMed ID: 19317958
[No Abstract] [Full Text] [Related]
20. Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.
Gentile S
Expert Opin Drug Metab Toxicol; 2015; 11(10):1585-97. PubMed ID: 26135630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
